IgA inducing peptide
IgA诱导肽
基本信息
- 批准号:6904672
- 负责人:
- 金额:$ 15.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-15 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyteT lymphocytecell differentiationclinical researchdendritic cellsenzyme linked immunosorbent assayflow cytometrygene expressiongene induction /repressiongenetic regulationgrowth factorhuman subjectimmune responseimmunodeficiencyimmunogeneticsimmunoglobulin Aimmunomagnetic separationmacrophagemonocytepeptidesprotein localization
项目摘要
DESCRIPTION (provided by applicant): IgA is the predominant Ig isotype in mucosal secretions of most mammalian species and is thus ideally localized to prevent pathogen entry. We took advantage of the large quantities of mucosal tissues, including lymph nodes and Peyer's patches in cattle to develop a cDNA library to probe for factors that regulate IgA expression. We identified a novel factor in the bovine, which impacts IgA production in vito and designated the factor, IgA Inducing Protein or IGIP. The general goal of this two-year innovative proposal is to extend our studies of this novel factor to humans and to elucidate the mechanisms by which IGIP influences IgA production. Our working hypothesis for the project is that interstitial dendritic cell derived- IGIP is conserved across mammalian species and is an essential component of T-dependent and independent pathways for induction of IgA-expressing cells. We also hypothesize that altered IGIP regulation in dendritic cells and/or B cells is a factor in selective IgA deficiency. The specific aims that will test this hypothesis are: 1) Use an established in vitro model to determine the role of IGIP in differentiation of IgA-expressing human B cells; 2) Identify the cellular sources of IGIP transcripts and protein in peripheral blood leukocytes including dendritic cells, T cells, B cells and monocyte/macrophages from normal individuals; 3) Compare the expression of IGIP transcripts and protein and the responsiveness to IGIP of peripheral blood leukocytes from patients with selective IgA deficiency. The proposed studies will be the first to establish the mechanism(s) by which a unique, recently identified factor acts in concert with known factors such as TGF-beta or IL-10 to promote IgA responses and should help clarify the role of human DC in the regulation of the IgA responses. In addition, the proposed studies will begin to examine determine the potential relationship between IGIP and clinical abnormality in IgA production.
描述(由申请人提供):IgA 是大多数哺乳动物物种粘膜分泌物中的主要 Ig 同种型,因此理想地定位以防止病原体进入。我们利用大量的粘膜组织,包括牛的淋巴结和派尔氏集结,开发了一个 cDNA 文库来探测调节 IgA 表达的因素。我们在牛体内发现了一种影响 IgA 体外产生的新因子,并将该因子命名为 IgA 诱导蛋白或 IGIP。这项为期两年的创新提案的总体目标是将我们对这种新因子的研究扩展到人类,并阐明 IGIP 影响 IgA 产生的机制。我们对该项目的工作假设是,间质树突细胞衍生的 IGIP 在哺乳动物物种中是保守的,并且是诱导 IgA 表达细胞的 T 依赖性和独立途径的重要组成部分。我们还假设树突状细胞和/或 B 细胞中 IGIP 调节的改变是选择性 IgA 缺乏的一个因素。检验这一假设的具体目标是: 1) 使用已建立的体外模型来确定 IGIP 在表达 IgA 的人类 B 细胞分化中的作用; 2)鉴定正常个体外周血白细胞(包括树突状细胞、T细胞、B细胞和单核/巨噬细胞)中IGIP转录本和蛋白质的细胞来源; 3)比较选择性IgA缺乏症患者外周血白细胞IGIP转录物和蛋白的表达以及对IGIP的反应性。拟议的研究将首次建立一种独特的、最近发现的因子与已知因子(如 TGF-β 或 IL-10)协同作用以促进 IgA 反应的机制,并应有助于阐明人类 DC 在 IgA 反应调节中的作用。此外,拟议的研究将开始确定 IGIP 与 IgA 产生临床异常之间的潜在关系。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Human IgA-inducing protein from dendritic cells induces IgA production by naive IgD+ B cells.
- DOI:10.4049/jimmunol.0801973
- 发表时间:2009-02-15
- 期刊:
- 影响因子:0
- 作者:Endsley MA;Njongmeta LM;Shell E;Ryan MW;Indrikovs AJ;Ulualp S;Goldblum RM;Mwangi W;Estes DM
- 通讯作者:Estes DM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Don MARK ESTES其他文献
Don MARK ESTES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Don MARK ESTES', 18)}}的其他基金
Vaccine Development for Burkholderia amllei and B. pseudomallei
鼻疽伯克霍尔德杆菌和类鼻疽伯克霍尔德杆菌的疫苗开发
- 批准号:
8233017 - 财政年份:2011
- 资助金额:
$ 15.1万 - 项目类别:
Vaccine Development for Burkholderia amllei and B. pseudomallei
鼻疽伯克霍尔德杆菌和类鼻疽伯克霍尔德杆菌的疫苗开发
- 批准号:
7676555 - 财政年份:2009
- 资助金额:
$ 15.1万 - 项目类别:
Non-invasive Optical Imaging of Select Agent Bacteria in Non-human Primates
非人类灵长类动物中选择性细菌的非侵入性光学成像
- 批准号:
7645250 - 财政年份:2009
- 资助金额:
$ 15.1万 - 项目类别:
Non-invasive Optical Imaging of Select Agent Bacteria in Non-human Primates
非人类灵长类动物中选择性细菌的非侵入性光学成像
- 批准号:
7914370 - 财政年份:2009
- 资助金额:
$ 15.1万 - 项目类别:
Discovery of subunit vaccine candidates against glanders
发现针对鼻疽的候选亚单位疫苗
- 批准号:
7649078 - 财政年份:2008
- 资助金额:
$ 15.1万 - 项目类别:
Phytoestrogens and innate immunity in ER deficient mice
ER 缺陷小鼠的植物雌激素和先天免疫
- 批准号:
6647790 - 财政年份:2002
- 资助金额:
$ 15.1万 - 项目类别:
Phytoestrogens and innate immunity in ER deficient mice
ER 缺陷小鼠的植物雌激素和先天免疫
- 批准号:
6575694 - 财政年份:2002
- 资助金额:
$ 15.1万 - 项目类别:
Phytoestrogens and innate immunity in ER deficient mice
ER 缺陷小鼠的植物雌激素和先天免疫
- 批准号:
6438587 - 财政年份:2001
- 资助金额:
$ 15.1万 - 项目类别:
Phytoestrogens and innate immunity in ER deficient mice
ER 缺陷小鼠的植物雌激素和先天免疫
- 批准号:
6419392 - 财政年份:2000
- 资助金额:
$ 15.1万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 15.1万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 15.1万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 15.1万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 15.1万 - 项目类别:
Discovery Grants Program - Individual